IN8BIO, Inc. SEC filings INAB

IN8BIO, Inc. has 410 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

IN8BIO, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Agreement ended
Jun 1, 2026 May 29, 2026
424B5 Prospectus supplement Jun 1, 2026 —
EFFECT Filing May 19, 2026 —
S-3/A Filing May 18, 2026 —
CORRESP Letter to the SEC May 15, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 POS Filing May 7, 2026 —
S-8 Employee stock plan registration May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Officer or director change, Shareholder vote results
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Mar 26, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 26, 2026 —
DEF 14A Proxy statement Mar 26, 2026 May 7, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Officer or director change
Feb 27, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Feb 9, 2026 Feb 4, 2026
424B3 Prospectus Jan 30, 2026 —
EFFECT Filing Jan 28, 2026 —
UPLOAD Letter from the SEC Jan 27, 2026 —
CORRESP Letter to the SEC Jan 26, 2026 —
S-3 Shelf registration Jan 20, 2026 —
D Filing Dec 30, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2025 Dec 18, 2025
8-K Current report
Other events
Nov 24, 2025 Nov 21, 2025
S-3 Shelf registration Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Other events
Jun 30, 2025 Jun 24, 2025
8-K Current report
Change to shareholder rights
Jun 4, 2025 Jun 3, 2025
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
8-K Current report
Shareholder vote results
May 9, 2025 May 8, 2025
10-K/A Amended annual report May 7, 2025 Dec 31, 2024
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
DEFR14A Filing Apr 29, 2025 —
8-K Current report
Other events
Apr 28, 2025 Apr 28, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Apr 28, 2025 Apr 27, 2025
ARS Annual report to shareholders Mar 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 17, 2025 —
DEF 14A Proxy statement Mar 17, 2025 May 8, 2025
S-8 Employee stock plan registration Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
PRE 14A Preliminary proxy statement Mar 5, 2025 May 8, 2025
8-K Current report
Officer or director change
Mar 5, 2025 Mar 4, 2025
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
8-K Current report
Listing notice
Feb 7, 2025 Feb 5, 2025
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Other events
Nov 25, 2024 Nov 25, 2024
EFFECT Filing Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
CORRESP Letter to the SEC Nov 8, 2024 —
UPLOAD Letter from the SEC Nov 7, 2024 —
S-3 Shelf registration Nov 4, 2024 —
D Filing Oct 15, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Oct 1, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Sep 11, 2024 Sep 6, 2024
8-K Current report
Officer or director change
Sep 6, 2024 Aug 30, 2024
8-K Current report
Exit or restructuring costs, Other events
Sep 4, 2024 Aug 30, 2024
424B5 Prospectus supplement Aug 12, 2024 —
8-K Current report
Other events
Aug 12, 2024 Aug 12, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results, Other events
Jun 13, 2024 Jun 12, 2024
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
424B5 Prospectus supplement May 7, 2024 —
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 12, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
S-8 Employee stock plan registration Jan 19, 2024 —
EFFECT Filing Jan 18, 2024 —
424B3 Prospectus Jan 18, 2024 —
CORRESP Letter to the SEC Jan 16, 2024 —
UPLOAD Letter from the SEC Jan 16, 2024 —
S-3 Shelf registration Jan 12, 2024 —
D Filing Dec 28, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 11, 2023 Dec 11, 2023
8-K Current report
Other events
Dec 11, 2023 Dec 11, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 7, 2023 Dec 6, 2023
8-K Current report
Other events
Nov 20, 2023 Nov 20, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Oct 12, 2023 Oct 12, 2023
S-8 POS Filing Aug 18, 2023 —
S-8 POS Filing Aug 18, 2023 —
S-8 Employee stock plan registration Aug 18, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
424B5 Prospectus supplement Jul 31, 2023 —
424B5 Prospectus supplement Jul 14, 2023 —
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 15, 2023
8-K Current report
Other events
Jun 5, 2023 Jun 5, 2023
8-K Current report
Other events
May 17, 2023 May 17, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
8-K Current report
Officer or director change
May 1, 2023 May 1, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 Jun 15, 2023
424B5 Prospectus supplement Apr 27, 2023 —
424B5 Prospectus supplement Apr 26, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Apr 24, 2023 Apr 24, 2023
8-K Current report
Other events
Apr 17, 2023 Apr 17, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
8-K Current report
Other events
Feb 23, 2023 Feb 23, 2023
8-K Current report
Other events
Jan 5, 2023 Jan 5, 2023
8-K Current report
Other events
Dec 12, 2022 Dec 12, 2022
8-K Current report
Other events
Dec 8, 2022 Dec 8, 2022
8-K/A Amended current report
Results of operations
Dec 6, 2022 Nov 10, 2022
EFFECT Filing Nov 21, 2022 —
CORRESP Letter to the SEC Nov 17, 2022 —
UPLOAD Letter from the SEC Nov 17, 2022 —
S-3 Shelf registration Nov 10, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Regulation FD disclosure
Oct 13, 2022 Oct 13, 2022
8-K Current report
Regulation FD disclosure
Aug 19, 2022 Aug 19, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Aug 16, 2022 Aug 11, 2022
424B4 Prospectus Aug 15, 2022 —
POS EX Filing Aug 12, 2022 —
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 12, 2022
EFFECT Filing Aug 11, 2022 —
S-1/A Amended registration statement Aug 9, 2022 —
CORRESP Letter to the SEC Aug 8, 2022 —
CORRESP Letter to the SEC Aug 8, 2022 —
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
S-1 Registration statement Aug 8, 2022 —
8-K Current report
Other events
Jul 27, 2022 Jul 27, 2022
UPLOAD Letter from the SEC Jul 26, 2022 —
DRS Filing Jul 20, 2022 —
8-K Current report
Regulation FD disclosure
Jun 8, 2022 Jun 8, 2022
8-K Current report
Shareholder vote results
Jun 2, 2022 Jun 1, 2022
S-8 Employee stock plan registration May 12, 2022 —
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 1, 2022
8-K Current report
Other events
Mar 28, 2022 Mar 28, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Other events
Dec 16, 2021 Dec 16, 2021
8-K Current report
Officer or director change
Dec 9, 2021 Dec 1, 2021
8-K Current report
Officer or director change
Nov 17, 2021 Nov 15, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
S-8 Employee stock plan registration Sep 10, 2021 —
10-Q Quarterly report Sep 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
Sep 10, 2021 Sep 10, 2021
8-K Current report
Bylaw or fiscal year change
Aug 3, 2021 Aug 3, 2021
424B4 Prospectus Jul 30, 2021 —
EFFECT Filing Jul 29, 2021 —
CORRESP Letter to the SEC Jul 26, 2021 —
CORRESP Letter to the SEC Jul 26, 2021 —
S-1/A Amended registration statement Jul 22, 2021 —
S-1/A Amended registration statement Jul 20, 2021 —
CORRESP Letter to the SEC May 7, 2021 —
S-1/A Amended registration statement May 7, 2021 —
UPLOAD Letter from the SEC Apr 15, 2021 —
S-1/A Amended registration statement Mar 31, 2021 —
CORRESP Letter to the SEC Nov 16, 2020 —
CORRESP Letter to the SEC Nov 16, 2020 —
CERT Filing Nov 10, 2020 —
8-A12B Form 8-a12b Nov 10, 2020 —
CORRESP Letter to the SEC Nov 9, 2020 —
CORRESP Letter to the SEC Nov 9, 2020 —
SEC STAFF LETTER Filing Nov 6, 2020 —
S-1/A Amended registration statement Nov 5, 2020 —
CORRESP Letter to the SEC Oct 27, 2020 —
S-1 Registration statement Oct 16, 2020 —
DRSLTR Filing Oct 9, 2020 —
DRS/A Filing Oct 9, 2020 —
UPLOAD Letter from the SEC Oct 7, 2020 —
SEC STAFF LETTER Filing Oct 1, 2020 —
DRS Filing Sep 10, 2020 —
D/A Filing Sep 4, 2020 —
D/A Filing Sep 20, 2018 —
D Filing May 22, 2018 —

Showing 198 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
INAB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1740279
Former names
Incysus Therapeutics, Inc. (until Sep 20, 2018)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.